Cited by 703Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesForensic Toxicology and Drug Analysis

Polydrug abuse: a review of opioid and benzodiazepine combination use

Open access
Jones, Jermaine D., Mogali, Shanthi, Comer, Sandra D.·2012·Drug and Alcohol Dependence

Abstract

This paper reviews studies examining the pharmacological interactions and epidemiology of the combined use of opioids and benzodiazepines (BZDs). A search of English language publications from 1970 to 2012 was conducted using PubMed and PsycINFO(®). Our search found approximately 200 articles appropriate for inclusion in this paper. While numerous reports indicate that the co-abuse of opioids and BZDs is ubiquitous around the world, the reasons for the co-abuse of these medications are not entirely clear. Though the possibility remains that opioid abusers are using BZDs therapeutically to self-medicate anxiety, mania or insomnia, the data reviewed in this paper suggest that BZD use is primarily recreational. For example, co-users report seeking BZD prescriptions for the purpose of enhancing opioid intoxication or "high," and use doses that exceed the therapeutic range. Since there are few clinical studies investigating the pharmacological interaction and abuse liability of their combined use, this hypothesis has not been extensively evaluated in clinical settings. As such, our analysis encourages further systematic investigation of BZD abuse among opioid abusers. The co-abuse of BZDs and opioids is substantial and has negative consequences for general health, overdose lethality, and treatment outcome. Physicians should address this important and underappreciated problem with more cautious prescribing practices, and increased vigilance for abusive patterns of use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2012.07.004

Cites

233 of 233 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients who use BZDs and have co-occurring AUD or OUD are at higher risk of morbidity and mortality because of cross-tolerance and combined CNS and respiratory depressant effects.

    “patients who use BZDs and have co-occurring alcohol use disorder (AUD) or OUD are at higher risk of morbidity and mortality because of the cross-tolerance and combined CNS and respiratory depressant effects of these substances.23,52”

    From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [52]

    Section 6 reports additive CNS and respiratory depression when benzodiazepines are combined with methadone, as well as an association between benzodiazepine–opioid use and fatal and non-fatal overdoses. The paper does not establish cross-tolerance as the cause of that risk or substantiate the same claim for patients with co-occurring alcohol use disorder; its alcohol discussion concerns co-use and treatment outcomes. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Combined use of BZDs and opioids increases the risk of adverse events, including fatal and nonfatal overdose, due to CNS depression caused by both medication classes.

    “Combined use of BZDs and opioids increases the risk of adverse events, including fatal and nonfatal overdose, due to the CNS depression caused by both medication classes (see “Patients Co-prescribed Benzodiazepines and Opioids” for further discussion).7,23,52”
  • Opioids and benzodiazepines were found to be co-abused by opioid users to enhance opioid intoxication.

    “Opioids and benzodiazepines were found to be co-abused by opioid users to enhance opioid intoxication (Jones et al., 2012).”
  • Previous research has demonstrated that benzodiazepines have greater misuse liability among those with histories of alcohol use disorder and increase the reinforcing effects of opioids when taken in combination.

    “Previous research has also demonstrated that benzodiazepines have greater misuse liability among those with histories of alcohol use disorder (23) and increase the reinforcing effects of opioids when they are taken in combination (24)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Substance Abuse and Mental Health Services Administration (SAMHSA) 2011a Center for Behavioral Health Quality and Statistics The DAWN Report: Drug-Related Emergency Department Visits Attributed to Intentional Poisoning Rockville, MD 27656745

Cited by

Sorted by citations

Authors
Jones, J. D., Mogali, S., & Comer, S. D.
Affiliations
Columbia University (US)
Corresponding author
Comer, Sandra D.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2012-09
Volume
125
Issue
1-2
Pages
8-18
ISSN
0376-8716 (ISSN-L)
OpenAlex
W1975817655
Cited by
703
References
233
Citations by year
2026: 26 · 2025: 26 · 2024: 52 · 2023: 45 · 2022: 58 · 2021: 63 · 2020: 88 · 2019: 65 · 2018: 67 · 2017: 64 · 2016: 59 · 2015: 39 · 2014: 32 · 2013: 16 · 2012: 1
FWCI
4.34
Type
journal article
Language
en
Open access
Locations
  • Drug and Alcohol Dependence (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Drug Abuse (DA-09236, DA031022, R01DA022222, R01DA016759, P50DA009236, K01DA030446, DA016759, DA030446-01A, DA022222, R01DA031022, T32DA007294)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
polydrug abuse, opioid-benzodiazepine combination, benzodiazepine misuse, opioid abuse, drug interactions, recreational drug use, self-medication, drug overdose, prescribing patterns, abuse liability
MeSH terms
Analgesics, Opioid, Benzodiazepines, Drug Interactions, Humans, Opioid-Related Disorders, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review